S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 6 47-6, 2003, Pages

  Song, Zhenyuan ^a   Barve, Shirish ^a   Chen, Theresa ^a   Nelson, Wendy ^a   Uriarte, Silvia ^a   Hill, Daniell ^a   McClain, Craig ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Inflammation; Liver injury

Indexed keywords

CYCLIC AMP; ENDOTOXIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; S ADENOSYLMETHIONINE;

ALCOHOL LIVER CIRRHOSIS; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; INFLAMMATION; LIVER INJURY; MACROPHAGE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0038586297     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00426.2002     Document Type: Article

References (39)

1. Arai T, Hiromatsu K, Kobayashi N, Takano M, Ishida H, Nimura Y, and Yoshikai Y. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J Immunol 155: 5743-5749, 1995.
2. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, and Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133: 43-52, 1995.
3. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, and Pohl LR. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298, 2002.
4. Bray GP, Tredger JM, and Williams R. S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology 15: 297-301, 1992.
5. Burchiel SW, Hanson K, and Warner NL. Clonal heterogeneity of cyclic AMP responsiveness: a comparison of malignant murine lymphoid cell lines. Int J Immunopharmacol 6: 35-42, 1984.
6. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, and McClain CJ. S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide-induced hepatic injury. Am J Physiol Gastrointest Liver Physiol 275: G125-G129, 1998.
7. Corrales F, Gimenez A, Alvarez L, Caballeria J, Pajares MA, Andreu H, Pares A, Mato JM, and Rodes J. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology 16: 1022-1027, 1992.
8. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Britti D, De Maio M, and Caputi AP. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis. Eur Cytokine Netw 12: 568-580, 2001.
9. DeCicco LA, Rikans LE, Tutor CG, and Hornbrook KR. Serum and liver concentrations of tumor necrosis factor alpha and interleukin-1β following administration of carbon tetrachloride to male rats. Toxicol Lett 98: 115-121, 1998.
10. Engstrom MA and Benevenga NJ. Rates of oxidation of the methionine and S-adenosylmethionine methyl carbons in isolated rat hepatocytes. J Nutr 117: 1820-1826, 1987.
11. Fedyk ER, Adawi A, Looney RJ, and Phipps RP. Regulation of IgE and cytokine production by cAMP: implications for extrinsic asthma. Clin Immunol Immunopathol 81: 101-113, 1996.
12. Giulidori P, Galli-Kienle M, Catto E, and Stramentinoli G. Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo. J Biol Chem 259: 4205-4211, 1984.
13. Grove J, Daly AK, Bassendine MF, Gilvarry E, and Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 46: 540-545, 2000.
14. Hill DB, D'Souza NB, Lee EY, Burikhanov R, Deaciuc IV, and de Villiers WJ. A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26: 74-82, 2002.
15. Kato M, Ikeda N, Matsushita E, Kaneko S, and Kobayashi K. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by concanavalin A. Hepatol Res 20: 232-243, 2001.
16. Khan MM, Sansoni P, Engleman EG, and Melmon KL. Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells. J Clin Invest 75: 1578-1583, 1985.
17. Khoruts A, Stahnke L, McClain CJ, Logan G, and Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13: 267-276, 1991.
18. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, and Deviere J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-α overproduction in alcoholic cirrhosis. Hepatology 22: 1436-1439, 1995.
19. Lieber CS. Role of S-adenosyl-L-methionine in the treatment of liver diseases. J Hepatol 30: 1155-1159, 1999.
20. Lieber CS, Casini A, DeCarli LM, Kim CI, Lowe N, Sasaki R, and Leo MA. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 11: 165-172, 1990.
21. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K, Demols A, Goldman M, Le Moine O, Geerts A, and Deviere J. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28: 1607-1615, 1998.
22. Lu SC S-adenosylmethionine. Int J Biochem Cell Biol 32: 391-395, 2000.
23. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila MA, Kanel G, and Mato JM. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 98: 5560-5565, 2001.
24. Mato JM, Camara J, Fernandez de Paz J, Caballeria L, Coll S, Caballero A, Garcia-Buey L, Beltran J, Benita V, Caballeria J, Sola R, Moreno-Otero R, Barrao F, MartinDuce A, Correa JA, Pares A, Barrao E, Garcia-Magaz I, Puerta JL, Moreno J, Boissard G, Ortiz P, and Rodes J. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 30: 1081-1089, 1999.
25. Merali S, Vargas D, Franklin M, and Clarkson AB Jr. S-adenosylmethionine and Pneumocystis carinii. J Biol Chem 275: 14958-14963, 2000.
26. Minai Y, Goto M, Kohyama M, Hisatsune T, Nishijima KI, and Kaminogawa S. Difference in signal transduction for IL-10 and IFN-gamma production in a CD8+ T cell clone. Cell Immunol 172: 200-204, 1996.
27. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, and Mosmann TR. Interleukin-10. Annu Rev Immunol 11: 165-190, 1993.
28. Nagaki M, Tanaka M, Sugiyama A, Ohnishi H, and Moriwaki H. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-α and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosaminesensitized mice. J Hepatol 31: 815-824, 1999.
29. Nelson DR, Lauwers GY, Lau JY, and Davis GL. Interleukin-10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118: 655-660, 2000.
30. O'Garra A, Chang R, Go N, Hastings R, Haughton G, and Howard M. Ly-1 B (B-1) cells are the main source of B cellderived interleukin-10. Eur J Immunol 22: 711-717, 1992.
31. Platzer C, Meisel C, Vogt K, Platzer M, and Volk HD. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int Immunol 7: 517-523, 1995.
32. Smith SR, Terminelli C, Denhardt G, Narula S, and Thorbecke GJ. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS and TNF-α-induced lethality. Cell Immunol 173: 207-214, 1996.
33. Suda T, O'Garra A, MacNeil I, Fischer M, Bond MW, and Zlotnik A. Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas. Cell Immunol 129: 228-240, 1990.
34. Szuster-Ciesielska A, Daniluk J, and Kandefer-Zerszen M. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis. Arch Immunol Ther Exp (Warsz) 48: 301-307, 2000.
35. Varela-Moreiras G, Alonso-Aperte E, Rubio M, Gasso M, Deulofeu R, Alvarez L, Caballeria J, Rodes J, and Mato JM. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment. Hepatology 22: 1310-1315, 1995.
36. Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, Carrieri V, and Albano O. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol 24: 407-415, 1989.
37. Wang SC, Ohata M, Schrum L, Rippe RA, and Tsukamoto H. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273: 302-308, 1998.
38. Watson WH, Zhao Y, and Chawla RK. S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumor necrosis factor-α. Biochem J 342: 21-25, 1999.
39. Zappia V, Galletti P, Porcelli M, Ruggiero G, and Andreana A. Uptake of adenosylmethionine and related sulfur compounds by isolated rat liver. FEBS Lett 90: 331-335, 1978.